AvevoRx Entering the Bleeding Disorders Market

Infusion pharmacy program targets patients with hemophilia, related conditions

Mary Chapman avatar

by Mary Chapman |

Share this article:

Share article via email
Illustration of a person receiving an intravenous infusion in the arm.

AvevoRx is entering the bleeding disorders market with a programĀ aimed at addressing theĀ dearth of accessible, personalized specialty infusion and pharmacy services for people with hemophilia and related conditions.

The North Carolina-based company, founded last year, provides specialty infusion pharmacy services in several states to at-home patients who have chronic and complex disorders.

ā€œThe bleeding disorders community is vastly underserved when patients are pressured to use ā€œbig box,ā€ mail order pharmacies,ā€ Philip Rielly, co-founder of AvevoRx, said in a press release. ā€œAvevoRx fights to provide best-in-class nursing services, clinical programs, and white glove consumer advocacy.ā€

Recommended Reading
A person uses a megaphone cone to make an announcement.

FDA Decision Expected in Early 2023 on Hem A Gene Therapy Roctavian

ā€œThe population of hemophilia patients in the United States hovers around 17,000 nationally, and we believe that the market remains strong for a highly specialized, customizable specialty pharmacy. We will use our extensive experience to advocate for our patients to access the best possible care,ā€ Rielly said.

The program, which is still being developed, will be led by industry veteran Norma Gowdy. With more than 10 years of experience in rare bleeding disorder patient management and program development, Gowdy will help structure the companyā€™s suite of bleeding disorder services.

ā€œBlood disorders treated through infusion therapies require a customer-centered approach that focuses on each patient individually,ā€ Gowdy said. ā€œAt AvevoRx, our commitment to quality, customized services are a natural fit in serving this population. That level of customer service is unmatched by our larger competitors, and will benefit patients, prescribing physicians, and plans alike.ā€

Gowdyā€™s industry work began in 2007, when she volunteered for a local chapter of the National Hemophilia Foundation. Throughout her career in specialty pharmacies of all sizes, she has been involved with sales, patient advocacy, and team leadership. Gowdyā€™s focus is providing providers and patients with tailored, personalized solutions.

AvevoRx makes therapies available through specialized pharmacy locations, field nurses, and nationwide auxiliary support. On a regional basis, the company also provides patients with short-term treatment needs with acute infusion therapies.

In addition to in-home infusion services, AvevoRx offers:

  • An easy referral and intake process
  • Nationwide therapy delivery
  • Pharmacy counseling
  • Self-infusion training
  • Therapy and disease education
  • Third-party reimbursement navigation and support
  • Access to third-party financial help
  • Around-the-clock daily support